Phibro Animal Health | PAHC - Fremdkapital





Fremdkapital Veränderung Datum
Align Technology USD 0 0 2024-12
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Assertio Holdings USD 39.17M 120K 2025-09
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Canopy Growth CAD 224.99M 1.34M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Henry Schein USD 2.33B 17M 2026-03
Idexx Laboratories USD 299.85M 74.99M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Merck USD 46.67B 77M 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Pacira USD 367.66M 4.53M 2026-03
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 1.05B 39.73M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.04B 3M 2026-03